资讯

More than eight million people were prescribed antidepressants last year, but a group of experts fear they may have some ...
Duloxetine is the first drug to gain FDA approval for the indication of diabetic peripheral neuropathic pain. However, randomized controlled clinical trials of duloxetine for this indication have ...
The researchers found that the weighted cumulative incidence rates of a fall-related visit at 30, 90, and 180 days were 103.60, 90.44, and 84.44 per 1,000 person-years, respectively, for ...
Cymbalta (duloxetine) is a brand-name prescription antidepressant drug that is administered in the form of an oral capsule. Cymbalta belongs to the serotonin-norepinephrine reuptake inhibitors (SNRIs) ...
Cymbalta is the brand name for duloxetine, and Effexor XR contains the active drug venlafaxine. These are prescription drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs). They are used ...
A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine capsules ...
More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II ...
A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug Administration for possibly containing a chemical increasing the risk of ...
The drug was voluntarily recalled by a New Jersey-based distributor, Rising Pharmaceuticals, Inc., on November 19, due to the "presence of N-nitroso-duloxetine impurity above recommended interim ...
Duloxetine Medication Information Learn everything you need to know about Duloxetine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.
The drug is manufactured by Towa Pharmaceutical Europe and distributed nationwide by BPI. The affected bottles are from lot number 220128 with an expiration date of 12/2024 and NDC of 51991-746-05.